Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Sunovion Pharmaceuticals Inc. (formerly Sepracor) engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders, and other illnesses. Its products include LUNESTA medicine that helps people sleep better; XOPENEX levalbuterol HCl inhalation solution; and BROVANA aformoterol tartrate inhalation solution. The company's products also comprise OMNARIS ciclesonide nasal spray; ALVESCO ciclesonide HFA inhalation aerosol; and LATUDA, an oral antipsychotic tablet for the treatment of schizophrenia. It offers products for the treatment of depression, epilepsy, neuropathic pain, and insomnia, as well as respiratory conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary diseases.

Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Zhejiang Zhiyi Pharmaceutical Co., Ltd., established on 2018-12-29, Business scope includes licensed projects:Drug Wholesale;Drug retail;Pharmaceutical commissioned production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Yangzhou Zhongbao Pharmaceutical Co., Ltd. is a Chinese company located in Yangzhou that manufactures pharmaceutical products. It was founded in 1991. Xiao Qiu Han is currently the CEO of the firm.

Beijing Wanquan Sunshine Medical Technology Co., Ltd., established on 2007-01-18, Business scope includes pharmaceutical research and development;technology transfer,Technical Services;Technology Import and Export,Import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sunovion Respiratory Development, Inc., a subsidiary of Sumitomo Chemical Co., Ltd., is a company headquartered in the United States that manufactures aerosol drug products.

Nanjing Huagai Pharmaceutical Co., Ltd., established on 2017-10-12, Business scope includes drug research and development,Production,Sales;Pharmaceutical Intermediates,Production of food additives,Sales;Warehousing(law,regulations,Except for those prohibited by the State Council or subject to approval);cargo freight;Import and export business of self-operated and agent commodities and technologies(Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of);Pharmaceutical and chemical technology transfer,technology development,Technical Advisory Services;Machine equipment cleaning,Install,repair;Pharmaceutical Glass Products,chemical reagent,Sales of mechanical equipment and spare parts(Except for the above items that require pre-approval);veterinary medicine,Research and development of health care products and raw materials,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Cosmetics Wholesale;Cosmetics Retail;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Part of Permira I.P. Ltd., Laboratorios Lesvi SA is a Spanish company located in Castelbisbal. The firm produces pharmaceutical products. On March 18, 2005 Invent Farma ehf acquired Laboratorios Lesvi SA.

Han Rui Pharmaceutical (Jingmen) Co., Ltd., established on 2019-01-03, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Technology Import and Export;Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Sales of labor protection products;Sales of daily chemical products;Domestic trade agent;trade broker;sales agent;Specialty Chemicals Sales(Free of Hazardous Chemicals);Biochemical product technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhan Haite Bio-Innovative Medicine Research Co., Ltd., established on 2021-11-09, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tianjin Famoxi Biomedical Technology Co., Ltd., established on 2019-12-24, Business scope includes biomedical technology development,consult,transfer,Serve;Pharmaceutical Intermediates(Does not contain Chinese herbal medicine)Sales,import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.

Shan Dongwei Pharmaceutical Co., Ltd., established on 1993-12-17, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Production of Class II Medical Devices;Drug import and export;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Disinfectant sales(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Sales of packaging materials and products;Manufacturing of medical packaging materials;Non-residential real estate leases;rental service(Licensed rental services not included);Machinery and Equipment Leasing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Inke SA, part of Permira I.P. Ltd., is a Spanish company located in Barcelona. The firm manufactures active pharmaceutical ingredients. It was founded in 1980.\nThe company says this about itself: Inke is a leading global manufacturer of inhalation active pharmaceutical ingredients (APIs) established in 1980 and based in Castellbisbal (Barcelona, Spain). With more than 25 years of experience in respiratory APIs, the company focuses on the development and manufacturing of high–added-value active substances for the pharmaceutical industry for use in inhalation therapies. The company holds great expertise for the treatment of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). This qualifies Inke to be a key supplier to major generic and branded companies worldwide, having twelve respiratory APIs for inhalation in its portfolio and distributing its products to more than 40 countries including Europe, the US, Japan, Korea, China and Turkey. Inke has been successfully inspected by every major global authority, including the US-FDA since 2002 (latest inspection in March 2023). It is fully EU-GMP compliant and holds ISO 9001 and ISO 14001 certifications. The company has a strong regulatory track-record with 10 Certificates of Suitability (CEPs), 26 EU-DMF, 21 US-DMF, 8 JP-DMF, 11 KR-DMF and 9 CN-DMF.